Rabeprazole and Peg-intron drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Rabeprazole (rabeprazole sodium) and Peg-intron (peginterferon alfa-2b). Common drug interactions include anorexia among females and platelet count decreased among males.

The phase IV clinical study analyzes what interactions people have when they take Rabeprazole and Peg-intron. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Rabeprazole?

Rabeprazole has active ingredients of rabeprazole sodium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 31,689 Rabeprazole users. Check the latest studies of Rabeprazole.

What is Peg-intron?

Peg-intron has active ingredients of peginterferon alfa-2b. eHealthMe is studying from 11,142 Peg-intron users. Check the latest studies of Peg-intron.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

14 people who take Rabeprazole and Peg-intron together, and have interactions are studied.

Rabeprazole and Peg-intron drug interactions.

What are the common drug interactions of Rabeprazole and Peg-Intron, by gender? *:

female:

Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
Blood calcium decreased
Hypoaesthesia (reduced sense of touch or sensation)
Myalgia (muscle pain)
Tetany (involuntary contraction of muscles)
Abasia (inability to walk)
Bronchopneumonia (inflammation of the lungs, arising in the bronchi or bronchioles)
Cholecystitis (infection of gallbladder)
Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
Delirium (wild excitement)

male:

Platelet count decreased
Melaena (the passage of black, tarry stools)
Ascites (accumulation of fluid in the abdominal cavity)
Autoimmune hepatitis
Decreased appetite
Dehydration (dryness resulting from the removal of water)
Delirium (wild excitement)
Diabetes mellitus inadequate control
Disseminated intravascular coagulation (systemic activation of blood coagulation)
Dyspnoea (difficult or laboured respiration)

What are the common drug interactions of Rabeprazole and Peg-Intron, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Abasia (inability to walk)
Gait disturbance
Hypoaesthesia (reduced sense of touch or sensation)

30-39:

Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
Melaena (the passage of black, tarry stools)
Platelet count decreased
Blood bilirubin increased
Blood calcium decreased
Lipoatrophy (localized loss of fat tissue)
Myalgia (muscle pain)
Tetany (involuntary contraction of muscles)
Varices oesophageal (enlarged and swollen veins at the bottom of the oesophagus, near the stomach)
White blood cell count decreased

40-49:

Mouth haemorrhage (bleeding from mouth)
Autoimmune hepatitis
Hypersensitivity

50-59:

Dehydration (dryness resulting from the removal of water)
Diabetes mellitus inadequate control
Dyspnoea (difficult or laboured respiration)
Gait disturbance
Headache (pain in head)
Hypoaesthesia (reduced sense of touch or sensation)
Incisional hernia (hernia caused by an incompletely-healed surgical wound)
Insomnia (sleeplessness)
Lymphocyte stimulation test positive
Malaise (a feeling of general discomfort or uneasiness)

60+:

Retinal exudates (discharge from retina)
Retinal haemorrhage (bleeding from retina)
Visual disturbance

What are the existing conditions these people have? *

Hepatitis C: 14 people, 100.00%
Reflux Oesophagitis (an oesophageal mucosal injury that occurs of gastric contents into the oesophagus): 1 person, 7.14%
Hiv Infection: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Rabeprazole and Peg-intron?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously